Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-01

FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride), a beta-blocker ophthalmic solution. The product is manufactured by Novartis Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BETOPTIC S (betaxolol hydrochloride)

Snippet

SUPPL AP for BETOPTIC S (BETAXOLOL HYDROCHLORIDE)